Karimi, Dennis http://orcid.org/0000-0003-3135-7435
Brorson, Stig
Midtgaard, Kaare S.
Fjalestad, Tore
Paulsen, Aksel
Olerud, Per
Ekholm, Carl
Wolf, Olof
Viberg, Bjarke
Stohlmann, Katharina
Jalal, Bamo
Cavallius, Christian
Pedersen, Esben S.
Frihagen, Frede
Stensbirk, Frederik
Illerström, Henrik
Knak, Jens
Nyholm, Anne Marie
Schønnemann, Jesper
Jensen, Joakim
Sundkvist, Jonas
Vinding, Mads
Siesing, Peter M.
Zivanovic, Srdjan
Kring, Søren
,
Article History
Received: 6 September 2021
Accepted: 18 April 2022
First Online: 2 June 2022
Declarations
:
: The trial will conform with the ethical principles of the Declaration of Helsinki [CitationRef removed]. The study is approved by the scientific ethics committee in Denmark (S-20200130), Sweden (2021-04596-216772), and Norway (282660), including the informed consent form and patient information sheet. Written, informed consent will be obtained from all participants. The management of personal data has been approved by the Data Protection Agency (reference number 20/60034). Any important changes to the trial will be advertised to the National Committee on Health Research Ethics for each country and registered at ExternalRef removed. Participants are covered by the insurance policies that apply to ordinary treatment.
: Not applicable.
: The authors declare that they have no competing interests.